Medicine & Life Sciences
vedolizumab
100%
Crohn Disease
50%
Inflammatory Bowel Diseases
44%
Ulcerative Colitis
39%
Tumor Necrosis Factor Inhibitors
38%
SARS Virus
16%
Celiac Disease
14%
Safety
14%
Lymphocytosis
14%
Adrenal Cortex Hormones
12%
Intraepithelial Lymphocytes
9%
Biopsy
9%
Calciphylaxis
8%
B-Lymphocytes
8%
Tumor Necrosis Factor-alpha
8%
Therapeutics
7%
Gluten-Free Diet
7%
Formulated Food
7%
Scabies
7%
Confidence Intervals
7%
Steroids
7%
Small Intestine
7%
Remission Induction
7%
Colitis
7%
Sarcopenia
6%
Mesentery
6%
Plastics
6%
Clinical Decision Support Systems
6%
Messenger RNA
6%
Hormone Replacement Therapy
6%
Infections
6%
Gastroenterology
6%
Licensure
5%
Cohort Studies
5%
Retrospective Studies
5%
Erectile Dysfunction
5%
Psoriasis
5%
Early Detection of Cancer
5%
Allergens
5%
Positron-Emission Tomography
5%